Rimegepant, sold under the brand name Nurtec ODT, is a medication for the treatment of an acute migraine with or without aura in adults. It is not used prophylactically. Approved for use in the United States in February 2020, rimegepant is produced and marketed by Biohaven Pharmaceuticals, based in New Haven, Connecticut.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Rimegepant brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Rimegepant medicine cost price in India.
The order for Rimegepant will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Rimegepant, sold under the brand name Nurtec ODT, is a medication for the treatment of an acute migraine with or without aura in adults. It is not used prophylactically
Rimegepant, powder for concentrate for solution for infusion
Generic Name: Rimegepant
NURTEC ODT orally disintegrating tablets: 75 mg
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Rimegepant on prescription and Import License in Patient's Name only.
For overseas patients, Rimegepant can be made available in Send your enquiry to find Rimegepant in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Rimegepant Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial For More Details
Lancet study reports positive phase III clinical trial results for rimegepant migraine peptide18 December 2020 611 For More Details